CN103214394A - Alkynyl imine derivative - Google Patents

Alkynyl imine derivative Download PDF

Info

Publication number
CN103214394A
CN103214394A CN2013101488639A CN201310148863A CN103214394A CN 103214394 A CN103214394 A CN 103214394A CN 2013101488639 A CN2013101488639 A CN 2013101488639A CN 201310148863 A CN201310148863 A CN 201310148863A CN 103214394 A CN103214394 A CN 103214394A
Authority
CN
China
Prior art keywords
replacement
heterocyclic radical
alkyl
aryl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013101488639A
Other languages
Chinese (zh)
Other versions
CN103214394B (en
Inventor
张文雄
周易
席振峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking University
Original Assignee
Peking University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University filed Critical Peking University
Priority to CN201310148863.9A priority Critical patent/CN103214394B/en
Publication of CN103214394A publication Critical patent/CN103214394A/en
Application granted granted Critical
Publication of CN103214394B publication Critical patent/CN103214394B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides an alkynyl imine derivative and a synthesis method thereof. According to the method, the 1-o-amino aryl substituted alkynyl imine derivative is prepared from carbodiimide, terminal alkyne, benzyne precursors and activated fluorine ions, the yield is high, and the synthesis method is scientific and reasonable, so that the universal method for synthesizing the alkynyl imine derivative with multiple substituent groups is provided. The method has the advantages of easily-obtained raw materials, wide application range and high separation yield; and experimental equipment and operation are simple and feasible, and further development and application are facilitated.

Description

A kind of alkynyl imine derivative
Technical field
The present invention relates to a kind of alkynyl imine derivative, relate in particular to alkynyl imine derivative and synthetic method thereof that 1 adjacent amido aryl replaces.
Background technology
Having in the multiple substituent alkynyl imine derivative molecule and have alkynyl imines fragment, is synthon important in the organic synthesis, and can guidance quality synthetic a series of nitrogen-containing heterocycle compounds also have important use at medicine aspect the synthetic and investigation of materials.
As described below, reported the application of 1-alkynyl group with imine moiety in synthetic.
" A Multicomponent Reaction of Arynes; Isocyanides; and Terminal Alkynes:Highly Chemo-and Regioselective Synthesis of Polysubstituted Pyridines and Isoquinolines.Angew.Chem.Int.Ed.2009; 48; 3458 " put down in writing the alkynyl imines can with alkyne reaction pyridine synthesis derivative, with the synthetic isoquinilone derivatives of benzyne reaction." A Novel Cu-Assisted Cycloisomerization of Alkynyl Imines:Efficient Synthesis of Pyrroles and Pyrrole-Containing Heterocycles.J.Am.Chem.Soc.2001; 123; 2074 ", " Metal-Catalyzed 1; 2-Shift of Diverse Migrating Groups in Allenyl Systems as a New Paradigm toward Densely Functionalized Heterocycles.J.Am.Chem.Soc.2008; 130,1440 " has all been put down in writing the alkynyl imines and has been become cycloisomerisation to generate pyrrole derivative under metal catalytic." Innovative Synthesis of4-Carbaldehydepyrrolin-2-ones by Zwitterionic Rhodium Catalyzed Chemo-and Regioselective Tandem Cyclohydrocarbonylation/CO Insertion of α-Imino Alkynes.J.Am.Chem.Soc.2001; 123,10214 " put down in writing rhodium catalysis alkynyl imines and inserted H 2/ CO 2The derivative of synthetic pyrrolinone." Stereodivergent Synthesis of β-Lactams Using Thermal Rearrangement of Aminocyclobutenones.Org.Lett.; 2009; 11,3266 " put down in writing Louis acid catalysis alkynyl imines and the reaction of thiazolinyl silicon ether generates cyclobutene ketone and azetinone." Chemodivergent Transformations of Alkynyl Imines.Synlett 2006,14,2325 " put down in writing the isomerization reaction of monovalence copper catalysis alkynyl imines and generated the condensed ring pyrroline.
The synthetic method of the alkynyl imine derivative that present domestic and foreign literature provides all has its limitation.Raw material is not easy to obtain, and needs catalyzer, and reaction conditions is violent, and productive rate is lower, and regioselectivity is relatively poor, and functional group's tolerance is relatively poor, and substituent kind is restricted.
Summary of the invention
The invention provides a kind of alkynyl imine derivative, especially 1 substituted alkynyl imine derivative.More specifically, provide a kind of 1 quilt alkynyl imine derivative that adjacent amido aryl replaces.
The present invention also provides a kind of synthetic method of alkynyl imine derivative of 1 replacement, especially the synthetic method of the alkynyl imine derivative of the adjacent amido aryl replacement of 1-.The alkynyl imines that this synthetic method replaces from the adjacent amido aryl of the synthetic 1-of the general industrial chemicals that cheaply is easy to get, the efficient height, cost is low, compares with existent method, has bigger advantage.
Technical scheme of the present invention is as follows:
The compound of a kind of general formula (1) expression,
In the formula,
Ar is an aromatic nucleus, represents monocycle, encircles and heterocycle more,
R 1, R 2, R 3Identical or different with R, represent that functional groups such as hydrogen atom, halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group, amide group replace or the C of non-replacement 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 2-12The C of alkoxy carbonyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical.
R 1, R 2Identical or different, derive from carbodiimide both sides substituting group, respectively the C of expression replacement or non-replacement 1-12The C of alkyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical,
R 3Derive from the Terminal Acetylenes substituting group, be the C of replacement of functional groups such as hydrogen atom, halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group, amide group or non-replacement 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 2-12The C of alkoxy carbonyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical,
R is positioned on the aromatic nucleus, derives from the substituting group of aryne precursor, represents that functional groups such as hydrogen atom, halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group, amide group replace or the C of non-replacement 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical.
The compounds of this invention preferably has the structure shown in the formula (IV):
Wherein,
R 1, R 2Identical or different, expression replaces or the C of non-replacement respectively 1-12The C of alkyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical,
R 3Represent that functional groups such as hydrogen atom, halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group, amide group replace or the C of non-replacement 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 2-12The C of alkoxy carbonyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical,
R 4, R 5, R 6, R 7Identical or different, represent the C of hydrogen atom, replacement or non-replacement respectively 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical.
The synthetic method of The compounds of this invention may further comprise the steps:
A) Terminal Acetylenes shown in the carbodiimide shown in the formula (I), the formula (II) and the benzyne precursor shown in the formula (III) are mixed, add the anhydrous tetrahydro furan dissolving;
B) add anhydrous potassium fluoride and anhydrous 18-hat-6, react under the room temperature;
C) reaction mixture to step b) carries out aftertreatment;
Figure BDA00003105391800032
Wherein,
R 1, R 2Identical or different, expression replaces or the C of non-replacement respectively 1-12The C of alkyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical,
R 3Represent that functional groups such as hydrogen atom, halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group, amide group replace or the C of non-replacement 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 2-12The C of alkoxy carbonyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical,
R 4, R 5, R 6, R 7Identical or different, represent the C of hydrogen atom, replacement or non-replacement respectively 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical.
About the used solvent of synthetic method, preferred anhydrous tetrahydro furan.
Synthetic method of the present invention, preferred 25 ℃ of the temperature of reaction of step a).
Synthetic method of the present invention, step b) is reacted 9h under 25 ° of C.
About the used active fluorine ions of synthetic method, be preferably villiaumite and crown ether, preferred, select Potassium monofluoride and 18-hat-6.
About synthetic method used solvent and fluorine source, anhydrous tetrahydro furan can substitute with anhydrous acetonitrile in the step a); When step a) was solvent with the anhydrous acetonitrile, step b) changed the anhydrous cesium fluoride of adding, reaction times 12h, but productive rate can reduce a little.
Synthetic method of the present invention, the mol ratio of preferred described benzyne precursor, carbodiimide, Terminal Acetylenes, Potassium monofluoride and 18-hat-6 is 2:1:1:(2-2.2): (2-2.2).
Synthetic method of the present invention, preferred described aftertreatment comprise that reaction solution concentrates, and concentration process adopts air distillation, underpressure distillation or evaporates with Rotary Evaporators.
Synthetic method of the present invention, preferred described last handling process is by chromatographic column separation and purification product, eluent is the mixed solvent of sherwood oil, ethyl acetate and methylene dichloride, and is preferred, and eluent is that volume ratio is a sherwood oil: ethyl acetate: methylene dichloride=40:1:1 mixed solvent.
The synthetic method of the adjacent amido aryl of 1-of the present invention substituted alkynyl imine derivative may further comprise the steps:
A) terminal alkyne shown in the carbodiimide shown in the formula (I), the formula (II) and the neighbour shown in the formula (III)-trimethyl silicon based phenol triflate are mixed, add the anhydrous tetrahydro furan dissolving;
B) with the reaction solution of Potassium monofluoride and 18-hat-6 adding step a), stirring reaction is 9 hours under the room temperature;
C) reaction solution with step b) obtains the adjacent amido aryl substituted alkynyl of 1 shown in the formula (IV) imines through aftertreatment;
The primitive reaction formula of above-mentioned reaction process is as follows:
Figure BDA00003105391800041
Wherein:
R 1, R 2Identical or different, expression respectively:
Carbonatoms is 1-12 or more alkyl, such as: methyl, ethyl, propyl group, sec.-propyl, butyl, isobutyl-..., undecyl, dodecyl, tridecyl ..., octadecyl etc., more preferably C 1-6Alkyl;
Carbonatoms is the cycloalkyl of 3-6, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;
Carbonatoms is the thiazolinyl of 1-12, such as propenyl, styryl etc.;
Carbonatoms is the aryl of 6-12, such as phenyl, xenyl, naphthyl etc.;
Or carbonatoms is the heterocyclic aryl of 2-5, such as thienyl, thiazolyl, pyridyl etc.
Above-mentioned group can be substituted base and replace, and described substituting group can be common C 1-4Alkyl or alkoxyl group, C 4-6Cycloalkyl, halogen atom or the like.
R 3Expression:
Hydrogen atom
Carbonatoms is 1-12 or more alkyl, such as: methyl, ethyl, propyl group, sec.-propyl, butyl, isobutyl-..., undecyl, dodecyl, tridecyl ..., octadecyl etc., more preferably C 1-6Alkyl;
Carbonatoms is the cycloalkyl of 3-6, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;
Carbonatoms is the thiazolinyl of 1-12, such as propenyl, styryl etc.;
Carbonatoms is the aryl of 6-12, such as phenyl, xenyl, naphthyl etc.;
Or carbonatoms is the heterocyclic aryl of 2-5, such as thienyl, thiazolyl, pyridyl etc.
Above-mentioned group can be substituted base and replace, and described substituting group can be common C 1-4Alkyl or alkoxyl group, C 4-6Cycloalkyl, halogen atom, also can represent functionalization substituting groups such as pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group, amide group.
R 4, R 5, R 6, R 7Identical or different, expression:
Hydrogen atom;
Carbonatoms is 1-12 or more alkyl, for example: methyl, ethyl, propyl group, sec.-propyl, butyl, isobutyl-, the tertiary butyl ..., undecyl, dodecyl, tridecyl ..., octadecyl etc., more preferably C 1-6The straight or branched alkyl;
Carbonatoms is the cycloalkyl of 3-6, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;
Carbonatoms is the thiazolinyl of 1-12, such as propenyl, cyclohexenyl;
Carbonatoms is the aryl of 6-12, such as phenyl, xenyl, naphthyl etc.;
Or carbonatoms is the heterocyclic aryl of 2-5, such as thienyl, thiazolyl etc.
Above-mentioned group all can be substituted base and replace, and described substituting group can be functional groups such as halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group, amide group.
Synthetic method of the present invention requires to carry out under the anhydrous and oxygen-free condition, and step is to carry out under nitrogen protection usually.
Employed fluorination reagent can be that Potassium monofluoride adds 18-hat-6 in the synthetic method of the present invention, also can be cesium fluoride.Solvent is respectively anhydrous tetrahydro furan or anhydrous acetonitrile.This tetrahydrofuran (THF) useful commercial reagent is back to mazarine through sodium-benzophenone before using and steams; Also can be the commercialization acetonitrile, after hydrolith refluxed 9 hours, under nitrogen protection, steam before using.
Adding 18-hat-6 with Potassium monofluoride in the synthetic method of the present invention is fluorination reagent, and tetrahydrofuran (THF) is that the reaction times of solvent is fluorination reagent than with the cesium fluoride, and acetonitrile is that the reaction times of solvent is short, and productive rate is higher.
The mol ratio preferable range of various reaction raw materials of the present invention or reagent is as shown in table 1:
The preferred molar ratio of various reaction raw materials of table 1. or reagent
Raw material or reagent Carbodiimide Terminal Acetylenes The benzyne precursor KF 18-hat-6 THF
Molar equivalent 1 1 2 2-2.2 2-2.2 Arbitrarily
The inventive method is not particularly limited the ratio of carbodiimide compound and tetrahydrofuran (THF), as long as reaction solution is evenly stirred, the carbodiimide compound of preferred 1mmol is dissolved in the ether solvent of volume greater than 3mL.
Use Potassium monofluoride and 18-hat-6 to provide active fluorine ions in the step b) of the present invention, it can make benzyne precursor converted in-situ is that benzyne participates in reaction.Therefore the adding molar equivalent of Potassium monofluoride and 18-hat-6 is for answering the equivalents of a little higher than benzyne.
The reaction times of the inventive method step a) is different because of the difference of substrate kind, and disappearing with the detection of benzyne precursor is as the criterion.Reaction in the general 9-12 of step a) hour finishes.
Step b) of the present invention is at room temperature reacted and is got final product, and also can adopt oil bath (for example silicone oil, paraffin wet goods) or other modes to heat when room temperature is too low, as long as keep temperature of reaction about 25 ° of C.
The simple before this reaction solution of aftertreatment concentrates, and the reaction solution concentration process can adopt Rotary Evaporators to concentrate.Product after concentrating is carried out purifying, and described purge process can be made eluent with certain polar solvent, and the chromatographic column separation gets final product.Selected eluent has certain difference according to the opposed polarity of product.Generally speaking, to select volume ratio for use be sherwood oil to eluent: ethyl acetate: methylene dichloride=40:1:1 mixed solvent.The chromatographic column of using such as laboratory silicagel column commonly used or high performance liquid chromatography etc.
On the other hand, the present invention also provides The compounds of this invention becoming cycloisomerisation to generate the application of condensed ring pyrroline derivative under cuprous salt catalysis.
The compounds of this invention alkynyl imines has purposes widely in the organic synthesis field, can be in order to synthesizing heterocyclic compounds, molecule in order to synthetic biologically active, in order to synthetic known and unknown compound, be used for the synthetic and exploitation of medicine, be used for the synthesis of biologically active molecule, be used for synthetic known and unknown type material.
The present invention utilizes carbodiimide, Terminal Acetylenes, benzyne precursor and active fluorine ions to prepare the adjacent amido aryl of 1-substituted alkynyl imine derivative, productive rate is higher, synthetic method is scientific and reasonable, thereby provides one synthetic to have a universal method of multiple substituent alkynyl imine derivative.This method raw material is easy to get, and is applied widely, high isolated yield, and experimental installation and operation is simple is convenient to further Application and Development.
Embodiment
Further describe the present invention below in conjunction with embodiment, but the scope that does not limit the present invention in any way.
Embodiment 1---(the R of compound shown in the preparation formula IVa 1=R 2=Cy, R 3=Ph, R 4=R 5=R 6=R 7=H):
Figure BDA00003105391800071
IVa
Under nitrogen protection, in the reaction tubes of 25mL, add the silica-based phenol triflate of the adjacent front three of 2mmol, 1mmolN, N '-dicyclohexylcarbodiimide and 1mmol phenylacetylene add the dissolving of 3mL tetrahydrofuran (THF).Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless flavescence.Concentration of reaction solution, the silicagel column decolouring separates, use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1:1 is made eluent, obtain alkynyl imine derivative N-{1-[2-(N-cyclohexyl-N-phenyl) phenyl]-3-phenyl-2-propynyl thiazolinyl }-hexahydroaniline 359mg(purity〉98%, yellow oily), isolated yield 78%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ 1.15-1.47 (m, 10H, 5CH 2), 1.57-1.81 (m, 8H, 4CH2), 2.00-2.14 (m, 2H, 1CH 2), 3.80-3.90 (m, 2H, 2CH), 6.53-6.64 (m, 3H, 3CH), 6.96-6.98 (m, 2H, 2CH), 7.05-7.14 (m, 3H, 3CH), 7.19-7.29 (m, 3H, 3CH), 7.33-7.47 (m, 2H, 2CH), 7.67 (d, J=7.6Hz, 1H, 1CH). 13CNMR (100MHz, CD 2Cl 2, Me 4Si): δ 25.15 (s, 2CH 2), 26.25 (s, 1CH 2), 26.38 (s, 1CH 2), 26.54 (s, 2CH 2), 31.62 (s, 2CH 2), 33.50 (s, 2CH 2), 58.38 (s, 1CH), 64.30 (s, 1CH), 83.45 (s, 1quat.C), 96.15 (s, 1quat.C), 115.27 (s, 2CH), 116.81 (s, 1CH), 122.42 (s, 1quat.C), 127.17 (s, 1CH), 128.54 (s, 2CH), 128.96 (s, 2CH), 129.36 (s, 1CH), 130.72 (s, 1CH), 130.77 (s, 1CH), 132.37 (s, 2CH), 132.64 (s, 1CH), 141.17 (s, 1quat.C), 142.90 (s, 1quat.C), 149.14 (s, 1quat.C), 149.48 (s, 1quat.C).
Embodiment 2---(the R of compound shown in the preparation formula IVb 1=R 2= iPr, R 3=4-MeO-Ph, R 4=R 5=R 6=R 7=H):
Figure BDA00003105391800081
IVb
Under nitrogen protection, in the reaction tubes of 25mL, add the silica-based phenol triflate of the adjacent front three of 2mmol, 1mmolN, N '-DIC and 1mmol add the dissolving of 3mL tetrahydrofuran (THF) to anisole acetylene.Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless flavescence.Concentration of reaction solution, the silicagel column decolouring separates, use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1:1 is made eluent, obtain N-{1-[2-(N-sec.-propyl-N-phenyl) phenyl]-3-(4-p-methoxy-phenyl)-2-propynyl thiazolinyl }-Isopropylamine 337mg(purity〉98%, yellow oily), isolated yield 82%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ 1.14-1.19 (m, 12H, 4CH 3), 3.75 (s, 3H, 1CH 3), 4.15-4.22 (m, 1H, 1CH), 4.25-4.32 (m, 1H, 1CH), 6.56-6.58 (m, 2H, 2CH), 6.72-6.74 (m, 2H, 2CH), 6.92-6.94 (m, 2H, 2CH), and 7.07-7.17 (m, 4H, 4CH), 7.31-7.34 (m, 1H, 1CH), 7.41-7.45 (m, 1H, 1CH), 7.66-7.67 (m, 1H, 1CH). 13CNMR (100MHz, CD 2Cl 2, Me 4Si): δ 20.90 (s, 2CH 3), 23.18 (s, 2CH 3), 49.59 (s, 1CH), 55.64 (s, 1CH 3), 55.74 (s, 1CH), 82.32 (s, 1quat.C), 97.03 (s, 1quat.C), 114.20 (s, 2CH), 115.68 (s, 2CH), 117.00 (s, 1quat.C), 127.10 (s, 1CH), 128.95 (s, 2CH), 129.73 (s, 1CH), 130.73 (s, 1CH), 130.77 (s, 1CH), 132.11 (s, 1CH), 133.98 (s, 2CH), 140.84 (s, 1quat.C), 142.78 (s, 1quat.C), 149.09 (s, 1quat.C), 149.88 (s, 1quat.C), 160.77 (s, 1quat.C).
Embodiment 3---(the R of compound shown in the preparation formula IVc 1=R 2= iPr, R 3=4-HCC-Ph, R 4=R 5=R 6=R 7=H):
Figure BDA00003105391800082
IVc
Under nitrogen protection, in the reaction tubes of 25mL, add the silica-based phenol triflate of the adjacent front three of 2mmol, 1mmolN, N '-DIC and 1mmol1, the 4-diacetylene-benzene adds the dissolving of 3mL tetrahydrofuran (THF).Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless flavescence.Concentration of reaction solution, the silicagel column decolouring separates, use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1:1 is made eluent, obtain N-{1-[2-(N-sec.-propyl-N-phenyl) phenyl]-3-(4-ethynyl phenyl)-2-propynyl thiazolinyl }-Isopropylamine 316mg(purity〉98%, yellow oily), isolated yield 78%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ 1.14-1.17 (m, 12H, 4CH 3), 3.22 (s, 1H, 1CH), 4.14-4.20 (m, 1H, 1CH), 4.24-4.31 (m, 1H, 1CH), 6.54-6.65 (m, 3H, 3CH), 6.90-6.92 (m, 2H, 2CH), and 7.05-7.14 (m, 3H, 3CH), 7.30-7.38 (m, 3H, 3CH), 7.44-7.48 (m, 1H, 1CH), 7.69 (d, J=7.3Hz, 1H, 1CH). 13CNMR (100MHz, CD 2Cl 2, Me 4Si): δ 20.84 (s, 2CH 3), 23.24 (s, 2CH 3), 49.56 (s, 1CH), 55.96 (s, 1CH), 79.56 (s, 1CH), 83.26 (s, 1quat.C), 84.78 (s, 1quat.C), 95.27 (s, 1quat.C), 115.52 (s, 2CH), 117.03 (s, 1CH), 122.81 (s, 1quat.C), 129.93 (s, 1quat.C), 127.25 (s, 1CH), 129.00 (s, 2CH), 130.69 (s, 1CH), 130.94 (s, 1CH), 132.15 (s, 2CH), 132.19 (s, 2CH), 132.24 (s, 1CH), 140.83 (s, 1quat.C), 142.68 (s, 1quat.C), 149.01 (s, 1quat.C), 149.11 (s, 1quat.C).
Embodiment 4---(the R of compound shown in the preparation formula IVd 1=R 2= iPr, R 3=4-NC-Ph, R 4=R 5=R 6=R 7=H):
Figure BDA00003105391800091
IVd
Under nitrogen protection, in the reaction tubes of 25mL, add the silica-based phenol triflate of the adjacent front three of 2mmol, 1mmolN, N '-DIC and 1mmol add the dissolving of 3mL tetrahydrofuran (THF) to the itrile group phenylacetylene.Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless flavescence.Concentration of reaction solution, the silicagel column decolouring separates, use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1:1 is made eluent, obtain N-{1-[2-(N-sec.-propyl-N-phenyl) phenyl]-3-(4-itrile group phenyl)-2-propynyl thiazolinyl }-Isopropylamine 320mg(purity〉98%, yellow oily), isolated yield 79%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ 1.14-1.19 (m, 12H, 4CH3), 4.15-4.30 (m, 2H, 2CH), and 6.54-6.64 (m, 3H, 3CH), 6.95-6.98 (m, 2H, 2CH), 7.04-7.08 (m, 2H, 2CH), 7.13-7.16 (m, 1H, 1CH), 7.37-7.40 (m, 1H, 1CH), 7.46-7.48 (m, 1H, 1CH), 7.70-7.72 (m, 1H, 1CH). 13CNMR (100MHz, CD 2Cl 2, Me 4Si): δ 20.75 (s, 2CH 3), 23.26 (s, 2CH 3), 49.64 (s, 1CH), 56.19 (s, 1CH), 86.42 (s, 1quat.C), 93.88 (s, 1quat.C), 112.51 (s, 1quat.C), 115.48 (s, 2CH), 117.11 (s, 1CH), 118.68 (s, 1quat.C), 127.02 (s, 1quat.C), 127.44 (s, 1CH), 129.07 (s, 2CH), 130.69 (s, 1CH), 131.20 (s, 1CH), 132.14 (s, 2CH), 132.44 (s, 1CH), 132.67 (s, 2CH), 140.75 (s, 1quat.C), 142.66 (s, 1quat.C), 148.73 (s, 1quat.C), 149.21 (s, 1quat.C).
Embodiment 5---(the R of compound shown in the preparation formula IVe 1=R 2= iPr, R 3=4-PhCO-Ph, R 4=R 5=R 6=R 7=H):
Figure BDA00003105391800101
IVe
Under nitrogen protection, in the reaction tubes of 25mL, add the silica-based phenol triflate of the adjacent front three of 2mmol, 1mmolN, N '-DIC and 1mmol1-phenyl-2-propine-1-ketone adds the dissolving of 3mL tetrahydrofuran (THF).Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless crimson.Concentration of reaction solution; the silicagel column decolouring separates; use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1.5:1.5 is made eluent; obtain N-{1-[2-(N-sec.-propyl-N-phenyl) phenyl]-3-benzoyl-2-propynyl thiazolinyl }-Isopropylamine 343mg(purity〉98%; the scarlet oily), isolated yield 84%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ 1.11 (d, J=6.1Hz, 6H, 2CH 3), 1.18 (d, J=6.4Hz, 6H, 2CH 3), 4.02-4.09 (m, 1H, 1CH), 4.25-4.32 (m, 1H, 1CH), and 6.43-6.51 (m, 3H, 3CH), 6.91-6.95 (m, 2H, 2CH), and 7.18-7.20 (m, 1H, 1CH), 7.18-7.20 (m, 1H, 1CH), and 7.37-7.53 (m, 4H, 4CH), 7.58-7.62 (m, 1H, 1CH), 7.76 (d, J=7.7Hz, 1H, 1CH), 7.85 (d, J=7.9Hz, 1H, 1CH). 13CNMR (100MHz, CD 2Cl 2, Me 4Si): δ 20.98 (s, 2CH 3), 23.31 (s, 2CH 3), 49.32 (s, 1CH), 56.83 (s, 1CH), 85.00 (s, 1quat.C), 91.90 (s, 1quat.C), 115.43 (s, 2CH), 117.51 (s, 1CH), 127.28 (s, 1CH), 128.93 (s, 2CH), 128.97 (s, 2CH), 129.76 (s, 2CH), 130.51 (s, 1CH), 131.55 (s, 1CH), 131.74 (s, 1CH), 134.59 (s, 1CH), 136.62 (s, 1quat.C), 139.37 (s, 1quat.C), 142.52 (s, 1quat.C), 146.77 (s, 1quat.C), 148.36 (s, 1quat.C), 177.19 (s, 1quat.C).
Embodiment 6---(the R of compound shown in the preparation formula IVf 1=R 2= iPr, R 3=3-thienyl, R 4=R 5=R 6=R 7=H):
Figure BDA00003105391800111
IVf
Under nitrogen protection, in the reaction tubes of 25mL, add the silica-based phenol triflate of the adjacent front three of 2mmol, 1mmolN, N '-DIC and 1mmol3-thiophene acetylene add the dissolving of 3mL tetrahydrofuran (THF).Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless flavescence.Concentration of reaction solution, the silicagel column decolouring separates, use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1:1 is made eluent, obtain N-{1-[2-(N-sec.-propyl-N-phenyl) phenyl]-3-(3-thienyl)-2-propynyl thiazolinyl }-Isopropylamine 290mg(purity〉98%, yellow oily), isolated yield 75%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ 1.14-1.17 (m, 12H, 4CH 3), 4.13-4.19 (m, 1H, 1CH), 4.24-4.31 (m, 1H, 1CH), 6.56-6.58 (m, 2H, 2CH), 6.64 (t, J=7.2Hz, 1H, 1CH), 6.73 (d, J=4.7Hz, 1H, 1CH), 6.96 (s, 1H, 1CH), 7.07-7.12 (m, 3H, 3CH), 7.15-7.17 (m, 1H, 1CH), 7.34 (t, J=7.4Hz, 2H, 2CH), 7.44 (t, J=7.5Hz, 2H, 2CH), 7.68 (d, J=6.8Hz, 2H, 2CH). 13CNMR (100MHz, CD 2Cl 2, Me 4Si): δ 20.80 (s, 2CH 3), 23.25 (s, 2CH 3), 49.54 (s, 1CH), 55.78 (s, 1CH), 82.81 (s, 1quat.C), 91.33 (s, 1quat.C), 115.56 (s, 2CH), 116.95 (s, 1CH), 121.43 (s, 1quat.C), 125.69 (s, 1CH), 127.17 (s, 1CH), 128.91 (s, 2CH), 130.14 (s, 1CH), 130.65 (s, 1CH), 130.79 (s, 1CH), 130.80 (s, 1CH), 132.18 (s, 1CH), 140.95 (s, 1quat.C), 142.68 (s, 1quat.C), 149.12 (s, 1quat.C), 149.18 (s, 1quat.C).
Embodiment 7---(the R of compound shown in the preparation formula IVg 1=R 2= iPr, R 3= nBu, R 4=R 5=R 6=R 7=H):
IVg
Under nitrogen protection, in the reaction tubes of 25mL, add the silica-based phenol triflate of the adjacent front three of 2mmol, 1mmolN, N '-DIC and 1mmol1-hexin add the dissolving of 3mL tetrahydrofuran (THF).Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless flavescence.Concentration of reaction solution, the silicagel column decolouring separates, and use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1:1 is made eluent, obtains N-{1-[2-(N-sec.-propyl-N-phenyl) phenyl]-2-heptyne base thiazolinyl }-Isopropylamine 253mg(purity〉98%, yellow oily), isolated yield 70%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ 0.83 (t, J=7.0Hz, 3H, 1CH 3), 1.05 (d, J=6.3Hz, 6H, 2CH 3), 1.15 (d, J=6.6Hz, 6H, 2CH 3), 1.25-1.27 (m, 4H, 2CH 2), 1.96 (d, J=6.7Hz, 2H, 1CH 2), 3.96-4.06 (m, 1H, 1CH), 4.19-4.28 (m, 1H, 1CH), 6.48-6.50 (m, 2H, 2CH), and 6.57-6.60 (m, 1H, 1CH), 7.04-7.11 (m, 3H, 3CH), 7.30-7.34 (m, 1H, 1CH), 7.39-7.43 (m, 1H, 1CH), 7.56-7.58 (m, 1H, 1CH). 13CNMR (100MHz, CD 2Cl 2, Me4Si): δ 13.66 (s, 1CH 3), 19.06 (s, 1CH2), 20.96 (s, 2CH 3), 22.35 (s, 1CH 2), 23.17 (s, 2CH 3), 30.54 (s, 1CH 2), 49.41 (s, 1CH), 55.55 (s, 1CH), 75.05 (s, 1quat.C), 99.29 (s, 1quat.C), 115.13 (s, 2CH), 116.61 (s, 1CH), 127.08 (s, 1CH), 128.69 (s, 2CH), 130.40 (s, 1CH), 130.61 (s, 1CH), 132.24 (s, 1CH), 141.52 (s, 1quat.C), 142.34 (s, 1quat.C), 148.90 (s, 1quat.C), 149.63 (s, 1quat.C).
Embodiment 8---(the R of compound shown in the preparation formula IVh 1=R 2= iPr, R 3= tBu, R 4=R 5=R 6=R 7=H):
Figure BDA00003105391800121
IVh
Under nitrogen protection, in the reaction tubes of 25mL, add the silica-based phenol triflate of the adjacent front three of 2mmol, 1mmolN, N '-DIC and 1mmol3,3-dimethyl butine adds the dissolving of 3mL tetrahydrofuran (THF).Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless flavescence.Concentration of reaction solution, the silicagel column decolouring separates, use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1:1 is made eluent, obtain N-{1-[2-(N-sec.-propyl-N-phenyl) phenyl]-4,4-dimethyl-valerylene base thiazolinyl }-Isopropylamine 263mg(purity〉98%, yellow oily), isolated yield 73%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ 1.03-1.05 (m, 15H, 5CH 3), 1.17 (d, J=6.6Hz, 6H, 2CH 3), 3.92-4.02 (m, 1H, 1CH), 4.19-4.28 (m, 1H, 1CH), 6.52 (d, J=8.2Hz, 2H, 2CH), 6.59 (t, J=7.2Hz, 1H, 1CH), 7.04-7.09 (m, 3H, 3CH), 7.28-7.32 (m, 1H, 1CH), 7.38-7.42 (m, 1H, 1CH), 7.56 (d, J=7.6Hz, 1H, 1CH). 13CNMR (100MHz, CD 2Cl 2, Me 4Si): δ 20.99 (s, 2CH 3), 23.00 (s, 2CH 3), 28.29 (s, 1quat.C), 30.43 (s, 3CH 3), 49.54 (s, 1CH), 55.15 (s, 1CH), 73.69 (s, 1quat.C), 106.62 (s, 1quat.C), 115.56 (s, 2CH), 116.80 (s, 1CH), 126.87 (s, 1CH), 128.76 (s, 2CH), 130.38 (s, 1CH), 130.61 (s, 1CH), 131.86 (s, 1CH), 141.14 (s, 1quat.C), 142.81 (s, 1quat.C), 148.84 (s, 1quat.C), 149.67 (s, 1quat.C).
Embodiment 9---(the R of compound shown in the preparation formula IVi 1=R 2= iPr, R 3=cyclopropyl, R 4=R 7=H, R 5=R 6=3.4--(CH) 4-):
Figure BDA00003105391800131
IVi
Under nitrogen protection, in the reaction tubes of 25mL, add 2mmol trifluoromethanesulfonic acid 3-(trimethyl silicon based)-2-naphthalene ester, 1mmolN, N '-DIC and 1mmol cyclopropyl acethlene add the dissolving of 3mL tetrahydrofuran (THF).Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless flavescence.Concentration of reaction solution, the silicagel column decolouring separates, use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1:1 is made eluent, obtain N-{2-[3-(N-sec.-propyl-N-(2-naphthyl)) naphthyl]-3-cyclopropyl-2-propynyl thiazolinyl }-Isopropylamine 351mg(purity〉98%, yellow oily), isolated yield 79%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ 0.35-0.62 (m, 4H, 2CH 2), 0.97 (d, J=6.2Hz, 6H, 2CH 3), 1.03-1.06 (m, 1H, 1CH), 1.29 (d, J=6.6Hz, 6H, 2CH 3), 3.89-3.95 (m, 1H, 1CH), 4.41-4.47 (m, 1H, 1CH), and 6.79-6.82 (m, 1H, 1CH), 6.94 (s, 1H, 1CH), 7.14 (t, J=7.4Hz, 1H, 1CH), 7.30 (t, J=7.5Hz, 1H, 1CH), 7.48-7.63 (m, 6H, 6CH), and 7.78-7.81 (m, 1H, 1CH), 7.92-7.94 (m, 1H, 1CH), 8.08 (s, 1H, 1CH). 13CNMR (100MHz, CD 2Cl 2, Me 4Si): δ 0.14 (s, 1CH), 9.01 (s, 2CH 2), 21.06 (s, 2CH 3), 23.11 (s, 2CH 3), 50.12 (s, 1CH), 55.56 (s, 1CH), 70.71 (s, 1quat.C), 102.86 (s, 1quat.C), 108.85 (s, 1CH), 119.66 (s, 1CH), 122.19 (s, 1CH), 126.20 (s, 1CH), 126.52 (s, 2CH), 127.05 (s, 1CH), 127.43 (s, 1quat.C), 127.54 (s, 1CH), 127.63 (s, 1CH), 128.07 (s, 1CH), 128.62 (s, 1CH), 130.04 (s, 1CH), 130.41 (s, 1CH), 132.40 (s, 1quat.C), 134.69 (s, 1quat.C), 135.23 (s, 1quat.C), 139.75 (s, 1quat.C), 140.15 (s, 1quat.C), 146.82 (s, 1quat.C), 149.10 (s, 1quat.C).
Embodiment 10---(the R of compound shown in the preparation formula IVj 1= tBu, R 2=Et, R 3=Ph, R 4=R 5=R 6=R 7=H):
Figure BDA00003105391800141
IVj
Under nitrogen protection, in the reaction tubes of 25mL, add the silica-based phenol triflate of the adjacent front three of 2mmol, 1mmolN-ethyl n '-tertiary butyl carbodiimide and 1mmol phenylacetylene, add the dissolving of 3mL tetrahydrofuran (THF).Add 2.2mmol anhydrous potassium fluoride and 2.2mmol18-hat-6 then, room temperature (25 ℃) reaction 9 hours.The reaction soln color is by colourless flavescence.Concentration of reaction solution, the silicagel column decolouring separates, use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=40:1:1 is made eluent, obtain N-{1-[2-(N-ethyl-N '-phenyl) phenyl]-3-phenyl-2-propynyl thiazolinyl }-hexahydroaniline 282mg(purity〉98%, yellow oily), isolated yield 74%.The nuclear magnetic data of this compound is as follows: 1HNMR (500MHz, CD 2Cl 2, Me 4Si): δ 1.21 (t, J=7.0Hz, 3H, 1CH 3), 1.39 (s, 9H, 3CH 3), 3.66 (q, J=7.0Hz, 2H, 1CH 2), 6.64-6.67 (m, 3H, 3CH), 7.00-7.11 (m, 4H, 4CH), 7.19-7.23 (m, 3H, 3CH), 7.26-7.29 (m, 2H, 2CH), 7.38-7.41 (m, 1H, 1CH), 7.54 (d, J=7.6Hz, 1H, 1CH). 13CNMR (125MHz, CD 2Cl 2, Me 4Si): δ 12.52 (s, 1CH 3), 29.35 (s, 3CH 3), 46.45 (s, 1CH 2), 57.55 (s, 1quat.C), 85.83 (s, 1quat.C), 97.24 (s, 1quat.C), 114.79 (s, 2CH), 117.26 (s, 1CH), 122.49 (s, 1quat.C), 126.29 (s, 1CH), 128.60 (s, 2CH), 129.13 (s, 2CH), 129.50 (s, 1CH), 129.99 (s, 1CH), 130.43 (s, 1CH), 130.78 (s, 1CH), 131.81 (s, 2CH), 140.69 (s, 1quat.C), 145.12 (s, 1quat.C), 148.09 (s, 1quat.C), 148.36 (s, 1quat.C).
Synthetic application examples---compound shown in the preparation formula V
Figure BDA00003105391800142
V
In the reaction tubes of 25mL, add 1mmolN-{1-[2-(N-sec.-propyl-N-phenyl) phenyl]-2-heptyne base thiazolinyl }-Isopropylamine (IVg) and 0.3mmolCuI, add 4mL exsiccant N, be stirred to CuI after the N-diethylformamide and dissolve fully.Add 0.5mL exsiccant Et 3N, 110 ℃ of lucifuge reaction 24h.System was reduced to room temperature after reaction was finished, and added 4mL water in reaction soln, and with normal hexane (4mL*3) extractive reaction liquid, merging, dry back concentrate organic extractant phase liquid.The silicagel column decolouring separates, and use sherwood oil: ethyl acetate: the mixed solvent of methylene dichloride=100:4:7 is made eluent, obtains pyrroline derivative (V) 263mg(purity〉98%, faint yellow oily), isolated yield 73%.The nuclear magnetic data of this compound is as follows: 1HNMR (400MHz, CD 2Cl 2, Me 4Si): δ=0.77-0.82 (m, 3H, 1CH 3), 1.01-1.05 (m, 3H, 1CH 21CH), 1.11-1.18 (m, 6H, 2CH 3), 1.22-1.26 (m, 3H, 1CH 21CH), 1.33 (s, 3H, 1CH 3), 2.11-2.26 (m, 2H, 1CH 2), 2.37-2.42 (m, 1H, 1CH), 2.78-2.79 (m, 1H, 1CH), 4.24-4.30 (m, 1H, 1CH), and 6.49-4.51 (m, 2H, 2CH), 6.60-6.64 (m, 1H, 1CH), 7.08-7.14 (m, 3H, 3CH), 7.33-7.47 (m, 2H, 2CH), 7.77-7.80 (m, 1H, 1CH). 13CNMR (100MHz, CD 2Cl 2, Me 4Si): δ 14.19 (s, 1CH 3), 20.78 (s, 2CH 3), 20.98 (s, 1CH 2), 25.03 (s, 1CH 3), 29.13 (s, 1CH), 33.51 (s, 1CH 2), 39.94 (s, 1CH 2), 41.48 (s, 1CH 2), 43.01 (s, 1CH), 48.94 (s, 1CH), 75.92 (s, 1quat.C), 114.54 (s, 2CH), 116.95 (s, 1CH), 127.26 (s, 1CH), 129.18 (s, 2CH), 130.82 (s, 1CH), 131.01 (s, 1CH), 132.31 (s, 1CH), 139.03 (s, 1quat.C), 142.16 (s, 1quat.C), 148.90 (s, 1quat.C), 173.14 (s, 1quat.C).

Claims (10)

1. the compound of a general formula (1) expression:
Figure FDA00003105391700011
In the formula,
Ar is an aromatic nucleus, represents monocycle, encircles and heterocycle more;
R 1, R 2, R 3Identical or different with R, the C of expression replacement or non-replacement 1_12The C of alkyl, replacement or non-replacement 1_12The C of alkoxyl group, replacement or non-replacement 2-12The C of alkoxy carbonyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical, described substituting group comprises hydrogen atom, halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group and amide group.
2. compound as claimed in claim 1 is characterized in that,
R 1, R 2Identical or different, derive from carbodiimide both sides substituting group, respectively the C of expression replacement or non-replacement 1-12The C of alkyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical;
R 3Derive from the Terminal Acetylenes substituting group, the C of expression replacement or non-replacement 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 2-12The C of alkoxy carbonyl, replacement or non-replacement 6-12The C of last aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical, described substituting group comprises hydrogen atom, halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group and amide group;
R is positioned on the aromatic nucleus, derives from the substituting group of aryne precursor, the C of expression replacement or non-replacement 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical, described substituting group comprises hydrogen atom, halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group and amide group.
3. compound as claimed in claim 2, it has the structure shown in the formula (IV):
Figure FDA00003105391700012
Wherein,
R 1, R 2Identical or different, expression replaces or the C of non-replacement respectively 1-12The C of alkyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical;
R 3The C of expression replacement or non-replacement 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 2-12The C of alkoxy carbonyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical, described substituting group comprises: hydrogen atom, halogen, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group and amide group;
R 4, R 5, R 6, R 7Identical or different, represent the C of hydrogen atom, replacement or non-replacement respectively 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical.
4. the synthetic method of the described compound of claim 1 is characterized in that, comprises the following steps:
A) Terminal Acetylenes shown in the carbodiimide shown in the formula (I), the formula (II) and the benzyne precursor shown in the formula (III) are mixed, add the anhydrous tetrahydro furan dissolving;
B) add anhydrous potassium fluoride and anhydrous 18-hat-6, react under the room temperature;
Figure FDA00003105391700021
Wherein,
R 1, R 2Identical or different, expression replaces or the C of non-replacement respectively 1-12The C of alkyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical;
R 3The C of expression replacement or non-replacement 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 2-12The C of alkoxy carbonyl, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical, described substituting group comprises C 1-4Alkyl or alkoxyl group, C 4-6Cycloalkyl, halogen atom, pseudohalogen, nitro, trifluoromethyl, carbonyl, ester group and amide group;
R 4, R 5, R 6, R 7Identical or different, represent the C of hydrogen atom, replacement or non-replacement respectively 1-12The C of alkyl, replacement or non-replacement 1-12The C of alkoxyl group, replacement or non-replacement 6-12The C of aryl, non-replacement 3-7Heterocyclic radical, on heterocycle substituted C 3-7Heterocyclic radical.
5. synthetic method as claimed in claim 4 is characterized in that, described step b) is reacted 9h down at 25 ℃.
6. synthetic method as claimed in claim 4 is characterized in that, described step a) anhydrous tetrahydro furan can substitute with anhydrous acetonitrile; When step a) was solvent with the anhydrous acetonitrile, step b) changed the anhydrous cesium fluoride of adding, reaction times 12h.
7. synthetic method as claimed in claim 4 is characterized in that, the mol ratio of described benzyne precursor, carbodiimide, Terminal Acetylenes, Potassium monofluoride and 18-hat-6 is 2: 1: 1: 2-2.2:2-2.2.
8. synthetic method as claimed in claim 4, it is characterized in that, comprise that also the reaction mixture to step b) carries out aftertreatment, described aftertreatment comprises that reaction solution concentrates, concentration process adopts air distillation, underpressure distillation or evaporates with Rotary Evaporators, described aftertreatment comprises also that by chromatographic column separation and purification product eluent is that volume ratio is a sherwood oil: ethyl acetate: methylene dichloride=40:1: 1 mixed solvent.
9. each described compound of the 1-3 of claim is at synthetic 1-pyrroline or contain the application of the medicine and the bioactive molecules of 1-pyrroline.
Each described compound of the 1-3 of claim synthetic nitrogen-containing heterocycle compound and bioactive molecules, derivative reaction, type material research and development, new compound synthetic with and in organic synthesis, be used as the application of synthetic intermediate.
CN201310148863.9A 2013-04-25 2013-04-25 A kind of Alkynyl imine derivative Expired - Fee Related CN103214394B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310148863.9A CN103214394B (en) 2013-04-25 2013-04-25 A kind of Alkynyl imine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310148863.9A CN103214394B (en) 2013-04-25 2013-04-25 A kind of Alkynyl imine derivative

Publications (2)

Publication Number Publication Date
CN103214394A true CN103214394A (en) 2013-07-24
CN103214394B CN103214394B (en) 2015-12-09

Family

ID=48812614

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310148863.9A Expired - Fee Related CN103214394B (en) 2013-04-25 2013-04-25 A kind of Alkynyl imine derivative

Country Status (1)

Country Link
CN (1) CN103214394B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105152967A (en) * 2015-09-28 2015-12-16 方美兰 Synthesis method for medical intermediate trifluoromethyl substituted cyclohexane compound

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005330413A (en) * 2004-05-21 2005-12-02 Fuji Photo Film Co Ltd Coating liquid for film formation, insulating film obtained using coating liquid and electronic device comprising the same
CN101643450A (en) * 2009-09-01 2010-02-10 北京大学 Synthesis method for multi substituted 2, 3-dihydro-4(1H)-pyrimidin thionone
CN101665470A (en) * 2009-09-18 2010-03-10 中国科学院上海有机化学研究所 Method for synthesizing cyclic sulphoxide imine, sulfenamide and sulfamide by stereospecificty
CN101798282A (en) * 2010-03-30 2010-08-11 中国科学院上海有机化学研究所 Multi-substituted fluorine-containing pyridine
WO2013038427A1 (en) * 2011-09-12 2013-03-21 Council Of Scientific & Industrial Research ARYLATED β-DICARBOIMYL COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005330413A (en) * 2004-05-21 2005-12-02 Fuji Photo Film Co Ltd Coating liquid for film formation, insulating film obtained using coating liquid and electronic device comprising the same
CN101643450A (en) * 2009-09-01 2010-02-10 北京大学 Synthesis method for multi substituted 2, 3-dihydro-4(1H)-pyrimidin thionone
CN101665470A (en) * 2009-09-18 2010-03-10 中国科学院上海有机化学研究所 Method for synthesizing cyclic sulphoxide imine, sulfenamide and sulfamide by stereospecificty
CN101798282A (en) * 2010-03-30 2010-08-11 中国科学院上海有机化学研究所 Multi-substituted fluorine-containing pyridine
WO2013038427A1 (en) * 2011-09-12 2013-03-21 Council Of Scientific & Industrial Research ARYLATED β-DICARBOIMYL COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BERNARD G. VAN DEN HOVEN等: "Innovative Synthesis of 4-Carbaldehydepyrrolin-2-ones by Zwitterionic Rhodium Catalyzed Chemo- and Regioselective Tandem Cyclohydrocarbonylation/CO Insertion of R-Imino Alkynes", 《J. AM. CHEM. SOC》 *
FENG SHA等: "A Multicomponent Reaction of Arynes, Isocyanides, and TerminalAlkynes: Highly Chemo- and Regioselective Synthesis of Polysubstituted Pyridines and Isoquinolines", 《ANGEW.CHEM.INT.ED.》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105152967A (en) * 2015-09-28 2015-12-16 方美兰 Synthesis method for medical intermediate trifluoromethyl substituted cyclohexane compound

Also Published As

Publication number Publication date
CN103214394B (en) 2015-12-09

Similar Documents

Publication Publication Date Title
JP5249219B2 (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
CN104926811B (en) The synthetic method of 3-cyanoimidazole also [1,2-a] pyridine compounds and application thereof
Nagao et al. Asymmetric trifluoromethylation of ketones with (trifluoromethyl) trimethylsilane catalyzed by chiral quaternary ammonium phenoxides
JP2008063278A (en) Method for producing 1-pyridin-4-yl-indole
Wang et al. Selectivities in the reaction of vicinal diimines and acyl chlorides
CN105732249A (en) Synthesis method of aryl alcohol compound and Escitalopram
CN113135840B (en) Synthetic method of conjugated alkenyl amidine compound
Deng et al. Addition of aldehydes with allyltrichlorosilane catalyzed by chiral bis-N–O secondary amides
CN111925356B (en) Synthesis method and application of chiral quinoline-imidazoline ligand
Pignataro et al. Readily available pyridine‐and quinoline‐N‐oxides as new organocatalysts for the enantioselective allylation of aromatic aldehydes with allyl (trichloro) silane
CN103214394B (en) A kind of Alkynyl imine derivative
Ohkura et al. Simple and highly diastereoselective synthesis of trifluoromethyl-containing myosmines via reaction between 2-(aminomethyl) pyridine and 1, 1, 1, 5, 5, 5-hexafluoro-2, 4-pentanedione
CN105820174A (en) Polysubstituted thienoindole derivative and preparation method thereof
CN113087667B (en) Synthesis method of imidazolidinone derivative
CN110028448B (en) Preparation method of 3-hydroxy-2,3-dihydroisoquinoline-1, 4-diketone compound
CN109734713B (en) 3-imido imidazo [1,2-a ] pyridine compound
Khanbabaee et al. Synthesis of novel chiral 6, 6′-bis (oxazolyl)-1, 1′-biphenyls and their application as ligands in copper (I)-catalyzed asymmetric cyclopropanation
CN105153003A (en) Synthetic method of trifluoromethyl seleno-alkyne compound
CN110577529A (en) Alpha-ketone compound of N- (hetero) aryl-7-azaindole and preparation method thereof
CN101643450B (en) Synthesis method for multi substituted 2, 3-dihydro-4(1H)-pyrimidin thionone
CN103539796A (en) Preparation method of levo praziquantel as well as intermediate thereof
CN115353514B (en) Fluoro-pyridopyrimidinone compounds and synthesis method thereof
Nowicki et al. Highly Selective Preparation of a Chiral Quaternary Allyl Aryl Piperidinedione by Palladium‐Catalyzed Asymmetric Allylation Under Solid–Liquid Phase‐Transfer Catalysis
JP5208928B2 (en) C2-ruthenocene bisphosphine ligand having only symmetric planar chirality and its synthesis method
CN110746336B (en) Green preparation method of N-methyl-2-cyano-3-arylpyrrole compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151209

Termination date: 20190425

CF01 Termination of patent right due to non-payment of annual fee